Investor Calendar

• The 2016 American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place June 3 to June 7, 2016 in Chicago.

Title: Ofranogene obadenovec (VB-111), an anti-cancer gene therapy in combination with bevacizumab to improve overall survival compared to bevacizumab monotherapy in patients with rGBM: A phase 2 historically controlled trial
Abstract: #2074
Abstract Link: http://abstract.asco.org/176/AbstView_176_167566.html
Session Type: Poster Session
Session Title: Central Nervous System Tumors
Date: Saturday, June 4, 2016
Time: 1:00 PM – 4:30 PM Location: Hall A
Poster Board: # 261
Presenter: Andrew Jacob Brenner, MD, PhD, The University of Texas Health Science Center at San Antonio